| Application no. and date | 18733481.8 (espacenet) (Federated) (European Patent Register), 20180604 | | Patent/reg. no. and date | DK/EP 3634380, 20240110 | | Publication date | 20200415 | | Priority no. and date | US 201715616409, 20170607, US 201715676373, 20170814, US 201715676356, 20170814 | | EP pub. no. and date |
EP 3634380 20200415 | | Effective date | | | Applicant/owner | Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300
Westlake Village, CA 91361, US | | Applicant ref. no. | | | Inventor | OSBORNE, David W., 4215 Creekside Court
Fort Collins, Colorado 80525, US | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 47/10 (2017.01) , A61K 9/00 (2006.01) , A61K 9/06 (2006.01) | | Title | INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST | | Int. application no. | US2018035854 | | Int. publication no. | WO2018226584 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
